GenAsia is a privately held limited liability corporation founded in New York in 1997. Incorporated in Manila in 1999, it serves as the ASEAN regional office of New York City-based GenAsia Biotech and Genesis Bio-Pharmaceuticals Inc. of Hackensack, New Jersey, USA, a major international distributor of plasma derivatives, specialty biological products and vaccines.

Supported by its US affiliates and business partners, GenAsia currently has marketing & exclusive distribution agreements covering the Philippines & select Southeast Asian markets with renowned biotechnology companies like  ZLB BEHRING, MEDIMMUNE, CANGENE, SHIRE, and PHARMION. GenAsia is also the exclusive partner of medical device Suppliers like STERYLAB, BIODERMIS and HAEMOSCOPE (TEG® System) for their complementary cutting-edge products in the Philippines and some ASEAN countries. All these promote GenAsia’s goal to find a niche in this highly specialized but under-served emerging markets.

Starting in the Philippines as an importer, licensee and specialty distributor, GenAsia believes in cost-effective, low-volume marketing of premium products that leverage its core strengths. Maintaining strategic business partnerships with end-users through third party payers, major healthcare facilities, non-profit organizations and specialized local dealers, the company can achieve maximum market penetration and competitiveness without unnecessary costs.

GenAsia’s scientific and clinical advisors include key opinion leaders in their therapeutic areas of expertise, e.g., Immuno-Hematology, Oncology, Transplantation, Cardiology, Advanced Wound Management, and other sub-specialties. Using science and evidence-based marketing with information technology. These elite groups of medical scientists and investigators participate in post licensing multi-center clinical trials and peer reviews for new product entities and delivery systems.

GenAsia’s proven regulatory and market development staff is experienced and knowledgeable in navigating the rigorous clearing and registration processes of the Intellectual Property Office (IPO), the Bureau of Food and Drugs (BFAD), as well as the Health (DOH) and Trade Departments (DOT). Such streamlining of regulatory filings and approvals help ensure that essential medicines are available when needed, on time.

GenAsia’s focused management team, both local and international, has combined strengths in sales and marketing technical specialty products. They are internationally recognized experts from their former affiliations with some of the world’s top bio-pharmaceutical and medical device companies.

GenAsia supplies to the most prestigious tertiary and secondary medical institutions in the Philippines, the Pacific Islands and parts of Southeast Asia, including international NGO’s in the region such as the World Health Organization (WHO).

GenAsia continues to seek and create global strategic partnerships to develop a market niche in new highly specialized therapeutic areas where the company can establish immediate market leadership.